Quell Therapeutics
A Research Associate at Quell contributes to the development of CAR-Treg therapies by conducting experiments, managing databases, and improving manufacturing processes. The role involves working closely with R&D and manufacturing teams in a dynamic environment focused on innovative Treg therapies.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2019
Quell Therapeutics is a clinical-stage biotechnology company focused on developing engineered regulatory T cell (Treg) therapies to treat severe immune- and inflammation-driven diseases. Using a precision cell‑engineering platform, Quell aims to create antigen‑specific Tregs that restore immune balance and reduce harmful inflammation. The company is advancing a pipeline of engineered Treg candidates through clinical development and works with patients, clinicians, and partners to translate discovery into new therapeutic options.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Quell Therapeutics.
Quell Therapeutics didn’t post a salary, so this is our estimate from similar listings.
Research Specialist A
University of Pennsylvania
Research Associate - III
Integrated Resources INC
Scientist, In Vivo CAR-T
Legend Biotech
Bench Scientist I
Integrated Resources INC
Research Scientist (Basic Life Research Scientist) 1 Year Fixed-Term
Stanford University
Research Associate (Contractor), Cell Therapy
Obsidian Therapeutics